Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HDX | hg38_v1_chrX_-_84502442_84502501 | 0.33 | 6.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_142800957 Show fit | 2.43 |
ENST00000466254.1
|
T cell receptor beta constant 2 |
|
chr12_+_56763316 Show fit | 2.26 |
ENST00000322165.1
|
hydroxysteroid 17-beta dehydrogenase 6 |
|
chr3_-_165837412 Show fit | 2.06 |
ENST00000479451.5
ENST00000488954.1 ENST00000264381.8 |
butyrylcholinesterase |
|
chr1_-_153390976 Show fit | 1.80 |
ENST00000368732.5
ENST00000368733.4 |
S100 calcium binding protein A8 |
|
chr1_-_159714581 Show fit | 1.45 |
ENST00000255030.9
ENST00000437342.1 ENST00000368112.5 ENST00000368111.5 ENST00000368110.1 |
C-reactive protein |
|
chr2_-_112836702 Show fit | 1.42 |
ENST00000416750.1
ENST00000263341.7 ENST00000418817.5 |
interleukin 1 beta |
|
chr1_-_169711603 Show fit | 1.22 |
ENST00000236147.6
ENST00000650983.1 |
selectin L |
|
chr11_+_60699605 Show fit | 1.07 |
ENST00000300226.7
|
membrane spanning 4-domains A8 |
|
chr1_+_62597510 Show fit | 0.93 |
ENST00000371129.4
|
angiopoietin like 3 |
|
chr1_+_84164684 Show fit | 0.84 |
ENST00000370680.5
|
protein kinase cAMP-activated catalytic subunit beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.0 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 2.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 2.3 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.7 | 2.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.0 | 1.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 1.8 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.5 | 1.4 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.1 | 1.4 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 1.4 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.0 | 1.2 | GO:0033198 | response to ATP(GO:0033198) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 2.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 2.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.2 | GO:0097224 | sperm connecting piece(GO:0097224) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 3.5 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 3.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 2.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 2.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 1.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 1.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 1.4 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.2 | 1.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 2.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 2.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |